产生G-CSF的肺肉类瘤用化学放射治疗治疗,然后用杜尔瓦卢马布治疗:一个病例报告
Naohito Hashimoto1, Kyoichi Kaira1, Tatsuhiko Uno1
1Department of Respiratory Medicine, International Medical Center, Saitama Medical University, Japan.
Respiratory medicine case reports
|December 24, 2025
概括
产生花细胞群刺激因子 (G-CSF) 的肺肉类瘤 (PSC) 的预后不佳. 多式疗法包括化学放射疗法和杜尔瓦卢马布巩固,在一个具有挑战性的病例中显示出持久的疾病控制.
科学领域:
- 在瘤学瘤学.
- 肺部医学 肺部医学
背景情况:
- 肺肉类瘤 (PSC) 是一种罕见的,激进的非小细胞肺癌亚型.
- 生产G-CSF的PSC存在独特的挑战,包括不良预后和对免疫检查点抑制剂 (ICI) 的可变反应.
研究的目的:
- 报告一种高PD-L1表达的产生G-CSF的PSC病例,并接受多式疗法治疗.
- 评估化学辐射疗法 (CRT) 和杜尔瓦卢马布整合在患有晚期G-CSF产生PSC的患者的疗效.
主要方法:
- 一名67岁的男性患者患有IIIB阶段的G-CSF产生PSC和高PD-L1 (95%) 接受了连续的CRT治疗 (放射治疗后每周进行碳白/帕克利塔塞尔).
- 启动了杜尔瓦卢马布的整合,但由于辐射肺炎而中止;给予皮质类固醇.
主要成果:
- 患者实现了超过12个月的持续疾病控制.
- 炎症标志物正常化,尽管停止治疗,但表现状况有所改善.
结论:
- 多模式治疗,包括CRT和可行的durvalumab巩固,可能为G-CSF产生的PSC提供临床益处.
- 对这种罕见而具有攻击性的癌症亚型的最佳管理策略需要进一步研究.
更多相关视频
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
27.8K
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
12.1K
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Rous Sarcoma Virus (RSV) and Cancer
6.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.1K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
